127 related articles for article (PubMed ID: 38109279)
1. An in silico approach to investigate the theranostic potential of coumarin-derived self-immolative luminescent probes.
Venkatesan S; Chanda K; Balamurali MM
Chem Biodivers; 2024 Feb; 21(2):e202301400. PubMed ID: 38109279
[TBL] [Abstract][Full Text] [Related]
2. Virtual Screening for Potential Phytobioactives as Therapeutic Leads to Inhibit NQO1 for Selective Anticancer Therapy.
Shreevatsa B; Dharmashekara C; Swamy VH; Gowda MV; Achar RR; Kameshwar VH; Thimmulappa RK; Syed A; Elgorban AM; Al-Rejaie SS; Ortega-Castro J; Frau J; Flores-Holguín N; Shivamallu C; Kollur SP; Glossman-Mitnik D
Molecules; 2021 Nov; 26(22):. PubMed ID: 34833955
[TBL] [Abstract][Full Text] [Related]
3. Cytosolic NQO1 Enzyme-Activated Near-Infrared Fluorescence Imaging and Photodynamic Therapy with Polymeric Vesicles.
Yao C; Li Y; Wang Z; Song C; Hu X; Liu S
ACS Nano; 2020 Feb; 14(2):1919-1935. PubMed ID: 31935063
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and In Silico Studies of C-4 Substituted Coumarin Analogues as Anticancer Agents.
Dandriyal J; Kaur K; Jaitak V
Curr Comput Aided Drug Des; 2021; 17(4):560-570. PubMed ID: 32598267
[TBL] [Abstract][Full Text] [Related]
5. Design, Synthesis and Biological Evaluation of 4, 6-Coumarin Derivatives as Anti- Cancer and Apoptosis-Inducing Agents.
Yan G; Luo J; Han X; Zhang W; Pu C; Zhou M; Zhong X; Hou X; Hou MZ; Li R
Anticancer Agents Med Chem; 2021; 21(17):2351-2367. PubMed ID: 33511941
[TBL] [Abstract][Full Text] [Related]
6. Chemical Characterization,
Ansari JA; Ahmad MK; Fatima N; Azad I; Mahdi AA; Satyanarayan GNV; Ahmad N
Anticancer Agents Med Chem; 2022; 22(20):3416-3437. PubMed ID: 35125087
[TBL] [Abstract][Full Text] [Related]
7. Design and Synthesis of Novel Coumarin Conjugated Acetamides as Promising Anticancer Agents: An In Silico and In Vitro Approach.
Mamatha SV; Belagali SL; Bhat M; Kumbar VM
Anticancer Agents Med Chem; 2021; 21(11):1431-1440. PubMed ID: 32664844
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and anticancer activities of some new coumarin derivatives including the triazole ring and their in silico molecular docking studies.
Menteşe E; Güner A; Polatlı E; Emirik M; Bektaş H; Kahveci B
Arch Pharm (Weinheim); 2021 Mar; 354(3):e2000284. PubMed ID: 33146895
[TBL] [Abstract][Full Text] [Related]
9. In silico and in vitro analysis of coumarin derivative induced anticancer effects by undergoing intrinsic pathway mediated apoptosis in human stomach cancer.
Perumalsamy H; Sankarapandian K; Veerappan K; Natarajan S; Kandaswamy N; Thangavelu L; Balusamy SR
Phytomedicine; 2018 Jul; 46():119-130. PubMed ID: 30097112
[TBL] [Abstract][Full Text] [Related]
10. Fluorescent Coumarin-Artemisinin Conjugates as Mitochondria-Targeting Theranostic Probes for Enhanced Anticancer Activities.
Zhang X; Ba Q; Gu Z; Guo D; Zhou Y; Xu Y; Wang H; Ye D; Liu H
Chemistry; 2015 Nov; 21(48):17415-21. PubMed ID: 26458147
[TBL] [Abstract][Full Text] [Related]
11. Synthesis, anticancer effect and molecular modeling of new thiazolylpyrazolyl coumarin derivatives targeting VEGFR-2 kinase and inducing cell cycle arrest and apoptosis.
Mohamed TK; Batran RZ; Elseginy SA; Ali MM; Mahmoud AE
Bioorg Chem; 2019 Apr; 85():253-273. PubMed ID: 30641320
[TBL] [Abstract][Full Text] [Related]
12. Hydrazide-hydrazones as Small Molecule Tropomyosin Receptor Kina se A (TRKA) Inhibitors: Synthesis, Anticancer Activities,
Alam MS; Lee DU
Med Chem; 2022; 19(1):47-63. PubMed ID: 35490310
[TBL] [Abstract][Full Text] [Related]
13. Coumarin-based inhibitors of human NAD(P)H:quinone oxidoreductase-1. Identification, structure-activity, off-target effects and in vitro human pancreatic cancer toxicity.
Nolan KA; Zhao H; Faulder PF; Frenkel AD; Timson DJ; Siegel D; Ross D; Burke TR; Stratford IJ; Bryce RA
J Med Chem; 2007 Dec; 50(25):6316-25. PubMed ID: 17999461
[TBL] [Abstract][Full Text] [Related]
14. New thiazol-hydrazono-coumarin hybrids targeting human cervical cancer cells: Synthesis, CDK2 inhibition, QSAR and molecular docking studies.
Abd El-Karim SS; Syam YM; El Kerdawy AM; Abdelghany TM
Bioorg Chem; 2019 May; 86():80-96. PubMed ID: 30685646
[TBL] [Abstract][Full Text] [Related]
15. Betulin-1,4-quinone hybrids: Synthesis, anticancer activity and molecular docking study with NQO1 enzyme.
Kadela-Tomanek M; Bębenek E; Chrobak E; Marciniec K; Latocha M; Kuśmierz D; Jastrzębska M; Boryczka S
Eur J Med Chem; 2019 Sep; 177():302-315. PubMed ID: 31158746
[TBL] [Abstract][Full Text] [Related]
16. The Inhibition Kinetics and Potential Anti-Migration Activity of NQO1 Inhibitory Coumarins on Cholangiocarcinoma Cells.
Khunluck T; Kukongviriyapan V; Senggunprai L; Duangarsong W; Prawan A
Integr Cancer Ther; 2019; 18():1534735418820444. PubMed ID: 30584780
[TBL] [Abstract][Full Text] [Related]
17. One-Pot Synthesis of Coumarin-Indomethacin Hybrids as COX-2 Targeting Probes for Cancer Imaging.
Wet-Osot S; Pewklang T; Chansaenpak K; Chudapongse N; Lai RY; Kamkaew A
ChemMedChem; 2021 May; 16(10):1660-1666. PubMed ID: 33586347
[TBL] [Abstract][Full Text] [Related]
18. Synthesis, In vitro, and Docking Analysis of C-3 Substituted Coumarin Analogues as Anticancer Agents.
Thakur A; Kaur K; Sharma P; Singla R; Singh S; Jaitak V
Curr Comput Aided Drug Des; 2021; 17(2):161-172. PubMed ID: 31987025
[TBL] [Abstract][Full Text] [Related]
19.
Maurya AK; Mishra N
J Biomol Struct Dyn; 2021 Nov; 39(18):7306-7321. PubMed ID: 32835632
[TBL] [Abstract][Full Text] [Related]
20. Coumarin derivatives with potential anticancer and antibacterial activity: Design, synthesis, VEGFR-2 and DNA gyrase inhibition, and in silico studies.
Emam SH; Hassan RA; Osman EO; Hamed MIA; Abdou AM; Kandil MM; Elbaz EM; Mikhail DS
Drug Dev Res; 2023 May; 84(3):433-457. PubMed ID: 36779381
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
